Research
1: He B, Wahl RL, Sgouros G, Du Y, Jacene H, Kasecamp WR, Flinn I, Hammes RJ, Bianco J, Kahl B, Frey EC. Comparison of organ residence time
estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studies.
Med Phys. 2009 May;36(5):1595-601. PubMed PMID: 19544775. 2: Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
J Nucl Med. 2009 May;50 Suppl 1:122S-50S. PubMed PMID: 19403881. 3: Kelloff GJ, Choyke P, Coffey DS; Prostate Cancer Imaging Working Group. Challenges in clinical prostate cancer: role of imaging.
AJR Am J Roentgenol. 2009 Jun;192(6):1455-70. PubMed PMID: 19457806. 4: Tatsumi M, Cohade C, Bristow RE, Wahl RL. Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET.
Mol Imaging Biol. 2009 Jul-Aug;11(4):229-35. Epub 2009 May 12. PubMed PMID: 19434463. 5: Ziessman HA, Chander A, Clarke JO, Ramos A, Wahl RL. The added diagnostic value of liquid gastric emptying compared with solid emptying alone.
J Nucl Med. 2009 May;50(5):726-31. Epub 2009 Apr 16. PubMed PMID: 19372480. 6: He B, Du Y, Segars WP, Wahl RL, Sgouros G, Jacene H, Frey EC. Evaluation of quantitative imaging methods for organ activity and residence time
estimation using a population of phantoms having realistic variations in anatomy and uptake.
Med Phys. 2009 Feb;36(2):612-9. PubMed PMID: 19292001. 7: Wahl RL, Reif JS. Temporal trends in bull semen quality: a comparative model for human health?
Environ Res. 2009 Apr;109(3):273-80. Epub 2009 Jan 31. PubMed PMID: 19181314. 8: Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, Rogers KM, Bolaños-Meade J, Borowitz MJ, Ambinder RF, Jones RJ, Swinnen LJ.
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
Biol Blood Marrow Transplant. 2009 Feb;15(2):242-8. PubMed PMID: 19167684. 9: Leboulleux S, Schroeder PR, Busaidy NL, Auperin A, Corone C, Jacene
HA, Ewertz ME, Bournaud C, Wahl RL, Sherman SI, Ladenson PW, Schlumberger M. Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
J Clin Endocrinol Metab. 2009 Apr;94(4):1310-6. Epub 2009 Jan 21. PubMed PMID: 19158200. 10: Jacene HA, Filice R, Kasecamp W, Wahl RL. 18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapy.
J Nucl Med. 2009 Jan;50(1):8-17. Epub 2008 Dec 17. PubMed PMID: 19091903. | | |
